Detalles de la búsqueda
1.
Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and Humans.
Drug Metab Dispos
; 51(4): 464-479, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653117
2.
Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in Humans.
Drug Metab Dispos
; 51(4): 451-463, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36639243
3.
In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters.
J Pharmacol Exp Ther
; 378(2): 108-123, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34074714
4.
Dapagliflozin prevents abdominal visceral and subcutaneous adipose tissue dysfunction in the insulin-resistant canine model.
Obesity (Silver Spring)
; 31(7): 1798-1811, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37221655
5.
Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers.
Front Pharmacol
; 12: 681455, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34483899
6.
Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs.
Eur J Pharm Sci
; 161: 105776, 2021 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33667667
7.
In-vitro metabolism of isotetrandrine, a bisbenzylisoquinoline alkaloid, in rat hepatic S9 fraction by high-performance liquid chromatography-atmospheric pressure ionization mass spectrometry.
J Pharm Pharmacol
; 56(6): 749-55, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15231040
Resultados
1 -
7
de 7
1
Próxima >
>>